title: Management of advanced prostate cancer.
authors.affiliation: Center for Tobacco Control Research, Odense, Denmark finn113edler@mail.tele.dk.
authors.forename: F
authors.initials: F
authors.lastname: von Eyben
authors.affiliation: Docrates Cancer Center, Helsinki, Finland.
authors.forename: T
authors.initials: T
authors.lastname: Kiljunen
authors.affiliation: Docrates Cancer Center, Helsinki, Finland.
authors.forename: A
authors.initials: A
authors.lastname: Kangasmaki
authors.affiliation: Docrates Cancer Center, Helsinki, Finland.
authors.forename: K
authors.initials: K
authors.lastname: Kairemo
authors.affiliation: Department of Radiation Oncology, Stanford University, San Francisco, USA.
authors.forename: R
authors.initials: R
authors.lastname: von Eyben
authors.affiliation: Docrates Cancer Center, Helsinki, Finland.
authors.forename: T
authors.initials: T
authors.lastname: Joensuu
mesh_terms: D000230:Adenocarcinoma / Q000628:therapy*; D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000628:therapy*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000628:therapy*; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D050071:Bone Density Conservation Agents; D043823:Taxoids